12.46
-0.16 (-1.27%)
-0.16 (-1.27%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.16 | -1.27% | 12.46 | 10:51:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.67 | 12.38 | 12.67 | 12.62 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 12.46 | 12.49 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 385 | 35,955 | $ 12.51 | $ 449,910 | 710,393 | 7.58 - 15.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:52:11 | 100 | $ 12.46 | USD |
Innoviva Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.26B | 101.39M | 57.64M | $ 261.02M | $ 231.86M | 1.43 | 6.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -798.00 | 7.20% |
Innoviva News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.30 | 13.03 | 12.25 | 12.71 | 539,829 | 0.16 | 1.3% |
| 1 Month | 11.95 | 13.06 | 11.95 | 12.53 | 499,765 | 0.51 | 4.27% |
| 3 Months | 9.38 | 13.06 | 9.22 | 11.41 | 691,595 | 3.08 | 32.84% |
| 6 Months | 14.39 | 14.425 | 9.21 | 11.54 | 705,987 | -1.93 | -13.41% |
| 1 Year | 14.30 | 15.69 | 7.58 | 12.42 | 739,609 | -1.84 | -12.87% |
| 3 Years | 14.81 | 20.54 | 7.58 | 14.07 | 793,738 | -2.35 | -15.87% |
| 5 Years | 8.71 | 20.54 | 7.58 | 13.33 | 798,824 | 3.75 | 43.05% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline. |
